JP2019510737A5 - - Google Patents

Download PDF

Info

Publication number
JP2019510737A5
JP2019510737A5 JP2018536507A JP2018536507A JP2019510737A5 JP 2019510737 A5 JP2019510737 A5 JP 2019510737A5 JP 2018536507 A JP2018536507 A JP 2018536507A JP 2018536507 A JP2018536507 A JP 2018536507A JP 2019510737 A5 JP2019510737 A5 JP 2019510737A5
Authority
JP
Japan
Prior art keywords
fceria
ige
lysine
allergic
carrier
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2018536507A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019510737A (ja
Filing date
Publication date
Priority claimed from EP16020009.3A external-priority patent/EP3192806A1/en
Application filed filed Critical
Publication of JP2019510737A publication Critical patent/JP2019510737A/ja
Publication of JP2019510737A5 publication Critical patent/JP2019510737A5/ja
Withdrawn legal-status Critical Current

Links

JP2018536507A 2016-01-13 2017-01-13 高親和性IgE受容体アルファ鎖(FceRIa) Withdrawn JP2019510737A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16020009.3 2016-01-13
EP16020009.3A EP3192806A1 (en) 2016-01-13 2016-01-13 Alpha chain of the high-affinity ige receptor (fceria)
PCT/EP2017/050646 WO2017121842A1 (en) 2016-01-13 2017-01-13 Alpha chain of the high-affinity ige receptor (fceria)

Publications (2)

Publication Number Publication Date
JP2019510737A JP2019510737A (ja) 2019-04-18
JP2019510737A5 true JP2019510737A5 (cg-RX-API-DMAC10.html) 2020-02-06

Family

ID=55357837

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018536507A Withdrawn JP2019510737A (ja) 2016-01-13 2017-01-13 高親和性IgE受容体アルファ鎖(FceRIa)

Country Status (8)

Country Link
US (1) US20190127438A1 (cg-RX-API-DMAC10.html)
EP (2) EP3192806A1 (cg-RX-API-DMAC10.html)
JP (1) JP2019510737A (cg-RX-API-DMAC10.html)
CN (1) CN108473551A (cg-RX-API-DMAC10.html)
AU (1) AU2017207854A1 (cg-RX-API-DMAC10.html)
CA (1) CA3010982A1 (cg-RX-API-DMAC10.html)
RU (1) RU2018129024A (cg-RX-API-DMAC10.html)
WO (1) WO2017121842A1 (cg-RX-API-DMAC10.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7780186B2 (ja) 2018-10-29 2025-12-04 コデクシス, インコーポレイテッド 操作されたdnaポリメラーゼバリアント
CN111100210B (zh) * 2019-01-30 2022-04-19 武汉九州钰民医药科技有限公司 一种Fc融合蛋白及其应用
EP3711772A1 (en) 2019-03-20 2020-09-23 Oslo Universitetssykehus HF Recombinant proteins and fusion proteins
MX2022000285A (es) 2019-07-08 2022-02-03 Gi Innovation Inc Dimero de polipeptido con alto contenido de acido sialico, que comprende el dominio extracelular de la subunidad alfa del receptor fc de ige y composicion farmaceutica que comprende el mismo.
CN110716054A (zh) * 2019-09-11 2020-01-21 天津医科大学 一种血清亲细胞性免疫球蛋白e的定量检测试剂盒
FR3108515B1 (fr) * 2020-03-26 2022-03-25 Ct Hospitalier Universitaire Toulouse Colonne d’aphérèse pour le traitement de la polyarthrite rhumatoïde
KR102468170B1 (ko) * 2020-07-17 2022-11-17 (주)지아이이노베이션 IgE Fc 수용체 알파서브유닛의 세포외 도메인 및 항-IL-4R 항체를 포함하는 융합단백질 및 이의 용도
JP2026511640A (ja) * 2023-03-29 2026-04-14 グリフォルス・ワールドワイド・オペレーションズ・リミテッド FcεRIβ自己抗体のレベルが低減された血漿製剤の組成物および調製方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4770774A (en) 1985-09-19 1988-09-13 Toray Industries, Inc. Column for removing β2 -microglobulin
US5985599A (en) 1986-05-29 1999-11-16 The Austin Research Institute FC receptor for immunoglobulin
US4962035A (en) 1987-12-01 1990-10-09 President And Fellows Of Harvard College DNA encoding IgE receptor alpha-subunit or fragment thereof
AU691297B2 (en) 1994-05-13 1998-05-14 Miltenyi Biotec Gmbh Sterile and pyrogen-free columns coupled to protein for binding and removal of substances from blood
IL116436A (en) * 1995-12-18 2006-12-31 Yissum Res Dev Co Fc?Á-PE CHIMERIC PROTEIN FOR TARGETED TREATMENT OF ALLERGY RESPONSES AND
AR008077A1 (es) 1996-07-26 1999-12-09 Talarico Salinas Laura Beatriz Un polipeptido de fusion o una sal del mismo, su uso, un proceso para prepararlos, una composicion farmaceutica que los comprende, y un vector.
GB9715387D0 (en) 1997-07-23 1997-09-24 Gould Hannah J Immunoglobulin-binding polypeptides and their use
US6057127A (en) * 1998-01-29 2000-05-02 Heska Corporation Equine Fc epsilon receptor alpha chain nucleic acid molecules and uses thereof
EP1006183A1 (en) 1998-12-03 2000-06-07 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Recombinant soluble Fc receptors
CA2385778A1 (en) * 1999-09-21 2001-03-29 Isis Innovation Limited Modulation of ige receptor cell surface expression
AU2001273456A1 (en) * 2000-07-13 2002-01-30 Hyseq, Inc. Soluble immunoglobulin e receptor alpha like molecules
US8354109B2 (en) 2005-12-13 2013-01-15 Suppremol Gmbh Multimeric Fc receptor polypeptides
WO2012140214A1 (en) 2011-04-13 2012-10-18 Biomay Ag IMMUNOAFFINITY SEPARATION MATERIALS COMPRISING ANTI-IgE ANTIBODY DERIVATIVES
CN102660569B (zh) 2012-04-21 2013-11-06 大连理工大学 一种重组人IgE受体蛋白的制备方法及应用

Similar Documents

Publication Publication Date Title
RU2018129024A (ru) Альфа-цепь высокоаффинного рецептора ige (fceria)
Ackaert et al. The impact of nitration on the structure and immunogenicity of the major birch pollen allergen Bet v 1.0101
RU2013120318A (ru) Антитела, связывающие il-4 и/или il-13, и их применение
US10144776B2 (en) Treatment of central nervous system disorders by intranasal administration of immunoglobulin G
BRPI0513798A (pt) anticorpos anti-cd154
TW200808821A (en) Antibody purification
AR058955A1 (es) Inmunglobulinas que se unen a interleuquina 13
Khan et al. Complement components as potential therapeutic targets for asthma treatment
MA29226B1 (fr) Anticorps diriges contre le recepteur alpha 1 de il-13 et leurs utilisations
EP3883602A4 (en) TAU PEPTIDE ANTIGENS AND ANTIBODIES BINDING TO THEM FOR THE TREATMENT OF TAUOPATHIES
GEP20115324B (en) Tweak binding antibodies
CN104066433A (zh) 药物制剂和其用于治疗花生过敏的用途
Rangel-Santos et al. Immunosuppresive role of principal toxin (crotoxin) of Crotalus durissus terrificus venom
Pandjaitan et al. Escherichia coli expression and purification of recombinant dog albumin, a cross-reactive animal allergen
Zhou et al. An IgE receptor mimetic peptide (PepE) protects mice from IgE mediated anaphylaxis
RU2010126590A (ru) Новые аллергены пшеницы
JP5635771B2 (ja) 抗炎症性及び抗アレルギー性環状ペプチド
Saavedra et al. Natural snake venom inhibitors and their pharmaceutical uses: challenges and possibilities
Srinivasan et al. A combined biochemical, biophysical and immunological approach towards the identification of celiac disease-specific wheat antigens
ES2535777T3 (es) Epítopos antigénicos de la proteína reguladora del factor de virulencia en Staphylococcus aureus y sus mimótopos y uso
Rossi et al. Anti-allergic properties of a new all-D synthetic immunoglobulin-binding peptide
JP7158015B2 (ja) ポリペプチドの凝集化抑制方法
Chung et al. IgE binding to peanut allergens is inhibited by combined D-aspartic and D-glutamic acids
EA200702634A1 (ru) Гуманизированные антитела, специфичные в отношении nogo-a, и их фармацевтические применения
JP5123858B2 (ja) IgEに結合する薬剤